Abbvie has a total of 47143 patents globally, out of which 17684 have been granted. Of these 47143 patents, more than 57% patents are active. United States of America is where Abbvie has filed the maximum number of patents, followed by Europe and Australia and it also seems reasonable as the biggest market for Abbvie is USA & Europe. Parallelly, USA seems to be the main focused R&D center and is also the origin country of Abbvie.
Abbvie was founded in 2013. The company doing business Pharmaceutical Industry. The Company offers a wide range of products in Biopharmaceutical, Biotechnology Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, and Women’s Health, etc. As of December 2021, Abbvie has a market cap of $215.45 Billion.
Do read about some of the most popular patents of Abbvie which have been covered by us in this article and also you can find Abbvie patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Abbvie patent portfolio.
How many patents does Abbvie have?
Abbvie has a total of 47143 patents globally. These patents belong to 8138 unique patent families. Out of 47143 patents, 26893 patents are active.
How many Abbvie patents are Alive/Dead?
How Many Patents did Abbvie File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Abbvie Applications Filed||Abbvie Patents Granted|
How Many Patents did Abbvie File in Different Countries?
Countries in which Abbvie Filed Patents
|United States Of America||7989|
|Hong Kong (S.A.R.)||1197|
|Eurasian Patent Organization||199|
|Gulf Cooperation Council||18|
|African Regional Industrial Property Organization||9|
|African Intellectual Property Organization||4|
|Republic of Moldova||4|
|Yugoslavia/Serbia and Montenegro||1|
Where are Research Centers of Abbvie Patents Located?
10 Best Abbvie Patents
US6306423B1 is the most popular patent in the Abbvie portfolio. It has received 542 citations so far from companies like Allergan, Medtronic and Holaira Inc.
Below is the list of 10 most cited patents of Abbvie:
|Publication Number||Citation Count|
Which Companies are using Abbvie Patents to Advance their Research?
If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.
The top citing companies in the Abbvie patent portfolio are Allergan Inc, Lifecell and Pharmacyclics.
List of the top forward citing Companies –
|Company||Number of Patents|
|Merz Pharma Gmbh||27|
|Boehringer Ingelheim International Gmbh||24|
Count of 102 and 103 Type Rejections based on Abbvie Patents
Top Abbvie Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of Abbvie US Patent Applications were Granted?
Abbvie (Excluding its subsidiaries) has filed 2502 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1856 have been granted leading to a grant rate of 77.4%.
Below are the key stats of Abbvie patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Abbvie?
|Law Firm||Total Application||Success Rate|
|Neal Gerber & Eisenberg||260||77.82%|
|Mccarter & English||183||57.06%|
|Womble Bond Dickinson||97||70.37%|
|Sterne Kessler Goldstein & Fox||58||43.10%|
“By investing in groundbreaking technologies & platforms, we aim to drive innovation within our pipeline and deliver better solutions to our patients.”
Human biology research has exploded in the last two decades, with breakthroughs in human genetics, cancer genomics, stem cell biology, bioinformatics, and systems biology all paving the way for new treatments. Advances in medicinal chemistry, as well as protein engineering, antibody drug conjugates, bispecifics, and immunotherapies, will put novel targets within reach in the future.
It is testing a number of innovative approaches for delivering more precise and effective medicines. Its research on innovative, targeted drug delivery promises to revolutionise the way disease is treated, from decreasing the effect of chemotherapy on healthy cells to providing new paths for treating neurological diseases.
Abbvie is always looking for new ways to ensure that its discoveries can be made and supplied to patients in a safe and high-quality manner.
EXCLUSIVE INSIGHTS COMING SOON
What are Abbvie’s key innovation segments?
What Technologies are Covered by Abbvie?
The chart below distributes patents filed by Abbvie in different countries on the basis of the technology protected in patents. It also represents the markets where Abbvie thinks it’s important to protect particular technology inventions
R&D Focus: How Abbvie search focus changed over the years?
Interested in knowing about the areas of innovation that are being protected by Abbvie?
EXCLUSIVE INSIGHTS COMING SOON